Cell Counting Market to Reach $3,196.0 Million Driven by AI-Enabled Automation and Precision Analytics

Cell counting market was valued at $1,760.0 million in 2025 and is projected to reach $3,196.0 million by 2035, growing at a CAGR of 6.2% during the forecast period (2026-2035). Artificial intelligence (AI) and machine learning (ML) are rapidly transforming the cell counting landscape by enabling automated cell counters to perform more accurately and intelligently. Modern AI?enhanced instruments use deep learning algorithms to analyze cell images, and even recognize subtle morphological differences that traditional methods often miss. By automating image interpretation and reducing manual steps, these systems minimize user variability and bias, streamline workflows, and enhance reproducibility. They can identify and classify complex cell patterns such as overlapping cells or debris with much greater reliability than manual counting techniques. Overall, AI?integrated cell counters not only improve precision and efficiency but also expand the analytical capabilities of laboratories in research, clinical, and bioprocessing settings. The rapid integration of artificial intelligence into diagnostic technologies is a major development within life sciences and clinical testing. In October 2024, GE HealthCare announced the launch of a new AI Innovation Lab to accelerate early-stage AI development across the company. The initiative supports GE HealthCare’s broader AI and digital strategy focused on embedding AI into medical devices and clinical decision-support applications. Backed by significant cloud infrastructure investments, the lab aims to scale AI innovations to improve care outcomes and operational efficiency across healthcare systems.

Browse the full report description of “Global Cell Counting Market Size, Share & Trends Analysis Report by Product Type (Instruments and Consumables), By Application (Medical Applications, Research, and Industrial), By End-User (Pharmaceuticals & Biotechnology companies, Research Institutes & CRO, and Hospitals and Diagnostic Laboratories) and Forecast 2026-2035.” Of https://www.omrglobal.com/industry-reports/cell-counting-market

Recent Product Innovations in the Global Cell Counting Market

The major companies operating in the global cell counting market include Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Merck KGaA (MilliporeSigma) and Thermo Fisher Scientific Inc. among others. Major players in the global cell counting market are focusing on advancing automation, analytical accuracy, and scalability to support growing demand from biopharmaceutical manufacturing and cell and gene therapy research.

• In October 2025, Switzerland-based NewBiologix launched the Xcell Portfolio, a suite of technologies aimed at improving the efficiency and scalability of viral vector production for gene therapy. The portfolio integrates engineered HEK293 cell lines with rAAV production, testing, and genomic analysis platforms. The launch is intended to support the transition of gene therapies from research to commercial-scale manufacturing.

• In April 2025, Logos Biosystems launched the LUNA-BX7 automated cell counter, a brightfield system designed to deliver high-throughput and reproducible cell counting using machine-learning–based analysis and advanced de-clustering algorithms. The instrument includes an upgrade option to dual-fluorescence optics, along with quality control and GMP-support features, addressing both current laboratory needs and future scalability requirements.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Merck KGaA (MilliporeSigma) and Thermo Fisher Scientific Inc. among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cell Counting Market Report Segment

By Product Type

• Instruments
• Consumables

By Application

• Medical Applications
• Research

By End-User

• Pharmaceuticals and Biotechnology companies
• Research Institutes and CRO
• Hospitals and Diagnostic Laboratories

Global Cell Counting Market Report Segment by Region

 North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America

Middle East & Africa

 To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cell-counting-market